siRNA-optimized Modifications for Enhanced In Vivo Activity
Current modifications used in small interfering RNAs (siRNAs), such as 2'-methoxy (2'-OMe) and 2'-fluoro (2'-F), improve stability, specificity or immunogenic properties but do not improve potency. These modifications were previously designed for use in antisense and not siRNA. W...
Saved in:
Main Authors: | Denise M Kenski (Author), Gabor Butora (Author), Aarron T Willingham (Author), Abby J Cooper (Author), Wenlang Fu (Author), Ning Qi (Author), Ferdie Soriano (Author), Ian W Davies (Author), W Michael Flanagan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chitosan and Its Structural Modifications for siRNA Delivery
by: Mona Y. Al-Absi, et al.
Published: (2023) -
5' Unlocked Nucleic Acid Modification Improves siRNA Targeting
by: Nicholas M Snead, et al.
Published: (2013) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
siRNA Versus miRNA as Therapeutics for Gene Silencing
by: Jenny K W Lam, et al.
Published: (2015)